Document is current
Any future updates will be listed below
-
Authors
van Vugt, Marianne J. H.
Stone, Julie A.
De Greef, “Rik” H. J. M. M.
Snyder, Ellen S.
Lipka, Leslie
Turner, David C.
Chain, Anne
Lala, Mallika
Li, Mengyao
Robey, Seth H.
Kondic, Anna G.
De Alwis, Dinesh
Mayawala, Kapil
Jain, Lokesh
Freshwater, Tomoko
-
Funding
Funding for this research was provided by:
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (NA)
- License Information
-
More Information
Article History
Received: 13 February 2019
Accepted: 4 July 2019
First Online: 8 August 2019
Ethics approval and consent to participate
: Patients from all studies provided voluntary written informed consent to participate before study start. The studies were conducted in accordance with the protocol, good clinical practice standards, and the Declaration of Helsinki. The protocols and subsequent amendments were approved by the appropriate institutional review board or ethics committee at each participating institution.
: The authors can confirm that all necessary patient consent forms were obtained prior to performing the study.
: LL, DCT, AC, ML, M. Li, SHR, AGK, DDA, KM, LJ, and TF are current or former employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. JAS and ESS are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, and hold stock in the company. MJHvV and HJMMdG have nothing to disclose. DCT was an employee of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ at the time of the analysis and is currently employed by GlaxoSmithKline, and M. Li was an employee of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ at the time of the analysis and is currently employed by Sanofi.
